Colorectal cancer natural history

Colorectal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Colorectal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Metastasis Treatment

Primary Prevention

Secondary Prevention

Follow-up

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Colorectal cancer natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Colorectal cancer natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Colorectal cancer natural history

CDC on Colorectal cancer natural history

Colorectal cancer natural history in the news

Blogs on Colorectal cancer natural history

Directions to Hospitals Treating Colorectal cancer

Risk calculators and risk factors for Colorectal cancer natural history

To view the natural history of familial adenomatous polyposis (FAP), click here
To view the natural history of hereditary nonpolyposis colorectal cancer (HNPCC), click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Saarah T. Alkhairy, M.D.; Elliot B. Tapper, M.D.; Roukoz A. Karam, M.D.[2]

## Overview[edit | edit source]

The progression from an adenomatous polyp to colorectal cancer may take 10-15 years. Complications may arise if the cancer is not eradicated or from the treatment itself. Complications include intestinal obstruction, gastrointestinal bleeding, metastasis, cancer recurrence, radiation therapy adverse effects, chemotherapy adverse effects, post-surgical complications, metachronous colon cancer, and death. The 5 year survival rates depend upon the stage of colorectal cancer.

## Natural history[edit | edit source]

* Colorectal cancer usually arises from a precursor lesion, the adenomatous polyp.
* The progression from an adenomatous polyp to colorectal cancer may take 10-15 years.
* The symptoms of colorectal cancer usually develop in the 6th decade of life, and start with symptoms such as change in bowel habits, hematochezia or bleeding per rectum, abdominal cramps or discomfort, rectal pain, tenesmus, and/or diminished caliber of stools.
* Constitutional symptoms such as nausea/vomiting, unexplained weight loss, unexplained loss of appetite, weakness, fatigue, dizziness may develop to suggest colorectal cancer.
* If the disease advances and spreads to other organs, the patient may present with dyspnea, cough with blood-stained sputum, persistent pain or discomfort in the chest, swelling in hands/feet, itchiness, jaundice, and/or dark-colored urine.[1]

## Complications[edit | edit source]

Common complications of colorectal cancer include:[2]

* Intestinal obstruction
* Intestinal perforation
* Fistula formation
* Gastrointestinal bleeding
* Metastasis
* Usually in the liver and lungs but may occur in other sites
* Cancer recurrence
* Local: site of the original tumor
* Regional: in lymph nodes near the primary tumor
* Distal: in another part of the body
* radiation therapy adverse effects including skin discoloration, skin burns, headache, fatigue, hair loss, nausea, vomiting, and/or confusion
* chemotherapy adverse effects including hair loss, fatigue, weakness, nausea, vomiting, risk of infection, and/or diarrhea
* Death

## Prognosis[edit | edit source]

Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.

The 5 year survival rate at diagnosis of colon cancer:[3]

Stage | 5-year Relative Survival Rate

|

I | 74.0%
IIA | 66.5%
IIB | 58.6%
IIC | 37.3%
IIIA | 73.1%
IIIB | 46.3%
IIIC | 28.0%
IV | 5.7%

The 5 year survival rate at diagnosis of rectal cancer:[3]

Stage | 5-year Relative Survival Rate

|

I | 74.1%
IIA | 64.5%
IIB | 51.6%
IIC | 32.3%
IIIA | 74.0%
IIIB | 45.0%
IIIC | 33.4%
IV | 6.0%

CEA level may also be directly related to the prognosis of disease, since its concentration correlates with the bulk of tumor tissue.

Poor prognostic factors of patients with hepatic metastasis include the following:

* Synchronous (diagnosed simultaneously) liver and primary colorectal tumors
* A short time between detecting the primary cancer and subsequent development of liver metastasis
* Multiple metastatic lesions
* Large-sized metastatic lesions, which can be measured by a high concentration of carcino-embryonic antigen (CEA)

## References[edit | edit source]

1. ↑ Winawer SJ (1999). "Natural history of colorectal cancer". Am J Med. 106 (1A): 3S–6S, discussion 50S-51S. PMID 10089106.
2. ↑ Tebbutt, N C (2003). "Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases". Gut. 52 (4): 568–573. doi:10.1136/gut.52.4.568. ISSN 0017-5749.
3. ↑ 3.0 3.1 Amin, Mahul (2017). AJCC cancer staging manual. Switzerland: Springer. ISBN 978-3-319-40617-6.

Template:WikiDoc Sources